Consumer News: FTC probes how companies use personal data to set prices and worker pay

State officials say the pricing policy threatens hospitals and patients

By Mark Huffman of ConsumerAffairs

• Missouri Attorney General Catherine Hanaway has ordered Eli Lilly to stop requiring hospitals to provide extensive prescription claims data before receiving federally mandated drug discounts.

• The state alleges that Eli Lilly cut off discounted drug pricing to University of Missouri Health Care after the hospital system refused to comply with the company's new policy.

• The attorney general warns that the restrictions could increase hospital costs and threaten access to medical care, especially in rural areas where hospitals depend on federal drug discounts.

Missouri's attorney general is taking on pharmaceutical giant Eli Lilly over a prescription drug pricing policy that state officials say is unlawful and could make it harder for hospitals to provide affordable medical care.

Attorney General Catherine Hanaway issued a cease-and-desist letter this week, ordering the drug manufacturer to stop requiring Missouri hospitals to turn over detailed prescription claims information as a condition of receiving discounted medications through a federal program. The outcome could have nationwide implications.

The dispute involves the federal 340B Drug Pricing Program, which requires participating pharmaceutical manufacturers to sell certain outpatient medications to eligible hospitals and healthcare organizations at reduced prices.

The savings help hospitals provide medical services to low-income and uninsured patients, particularly in rural communities where healthcare facilities often operate on tight budgets.

Big Pharma does not get to bully Missouri hospitals or hold prescription drug prices hostage, Hanaway said in announcing the action.

Eli Lilly is abusing its market power to impose higher prescription prices in Missouri. These tactics fall hardest on rural communities that depend on the 340B program to keep clinics open and ensure patients receive the care they need.

Hospital lost access to discounts

According to the attorney general's office, Eli Lilly implemented a policy earlier this year requiring hospitals participating in the 340B program to submit detailed claims data for every dispensing of a Lilly medication, regardless of where the prescription was filled.

The state contends that the requirement goes beyond what is necessary to administer the federal discount program. University of Missouri Health Care initially refused to comply with the policy.

On July 2, 2026, Eli Lilly cut off the health system's access to discounted 340B pricing, according to the attorney general.

Facing mounting financial losses and concerns about the potential impact on patient care, MU Health Care eventually agreed to provide the requested information temporarily while preserving its legal rights.

The attorney general's office says the health system is now incurring significant administrative expenses to comply with the requirements.

MU Health Care spokesman Eric Maze welcomed the state's intervention.

We appreciate the Missouri Attorney General's efforts to protect patient privacy and preserve our ability to provide high-quality care to all patients, Maze told ABC 17 News.

Why the dispute matters to consumers

Although the dispute centers on pricing arrangements between a pharmaceutical manufacturer and hospitals, the outcome could have consequences for patients.

The 340B program allows eligible hospitals and clinics to purchase outpatient prescription drugs at prices below those normally charged.

Hospitals can use the resulting savings to support services that might otherwise be difficult to maintain, including cancer treatment, emergency care, and assistance for patients who cannot afford their medications.

If hospitals lose access to those discounts, their operating expenses can increase substantially.

That doesn't necessarily mean consumers will immediately pay more at the pharmacy counter. However, higher costs could put pressure on hospital budgets, potentially resulting in reduced services or fewer financial assistance programs.

Rural hospitals may be especially vulnerable because many already face financial challenges and serve communities with limited alternatives for medical care.

The attorney general argues that Eli Lilly's policy threatens the financial stability of those facilities, and ultimately, patients' access to treatment.

Eli Lilly says the data helps prevent abuse

The drugmaker has maintained that collecting claims information is necessary to identify duplicate discounts and prevent fraud, waste, and abuse in the 340B program. The company has also said the information helps identify overlapping discounts under the Inflation Reduction Act.

Eli Lilly expanded its data-reporting requirements earlier this year, prompting objections from hospitals and legal challenges in other states.

Hospital groups argue that the requirements impose costly administrative burdens and can improperly interfere with access to federally required discounts.

State threatens legal action

Hanaway's cease-and-desist letter directs Eli Lilly to end its claims-data submission requirement for Missouri hospitals participating in the 340B program.

The company has also been ordered to stop using claims information collected under the disputed policy.

The attorney general alleges that Eli Lilly misled consumers by representing that eligible hospitals could purchase drugs at federally required discounted prices while withholding those discounts from facilities that refused to provide additional data.

The state contends that the conduct violates Missouri consumer protection law.

More than 7,800 packages of the popular dairy-free butter were distributed to 10 states

By Mark Huffman of ConsumerAffairs

• Miyokos Creamery European Style Salted Plant Milk Butter has been recalled because of possible contamination with E. coli, yeast, and mold.

• The recall affects 1,304 cases, containing 7,824 individual packages, distributed in 10 states.

• The FDA has classified the recall as Class II, meaning the product could cause temporary or medically reversible health problems.

Consumers who have purchased Miyokos Creamery European Style Salted Plant Milk Butter are being urged to check their refrigerators and freezers following a recall involving possible contamination with E. coli, yeast, and mold.

According to the U.S. Food and Drug Administration (FDA), Prosperity Organic Foods Inc., based in Boise, Idaho, voluntarily initiated the recall on September 11, 2026. The FDA classified the action as a Class II recall on October 23.

The recall covers 1,304 cases of the plant-based butter, with six eight-ounce packages per case. That amounts to 7,824 individual packages that may have reached consumers.

The product was distributed in Connecticut, Florida, Georgia, Illinois, Indiana, Iowa, Maryland, New Hampshire, New Jersey, and Wisconsin.

The recall remains ongoing. No illnesses have been reported in connection with the recalled butter, according to published reports.

How to identify the recalled butter

Consumers should check their packages for the following identifying information:

• Product: Miyokos Creamery European Style Salted Plant Milk Butter

• Package size: 8 ounces (227 grams)

• UPC: 857554005773

• Lot code: 07871 on the retail package; 1007871 on the shipping case

• Best-by date: November 5, 2026

The product is sold as a refrigerated, dairy-free alternative to conventional butter and is commonly used for spreading, cooking, and baking.

Retailer Wegmans also posted a recall notice identifying the affected product and offering customers a full refund.

What are the health risks?

The FDA's Class II designation means exposure to the recalled product could cause temporary or medically reversible health consequences, while the probability of serious adverse health effects is considered remote.

However, certain strains of E. coli can cause significant illness, particularly among young children, older adults and people with weakened immune systems.

Symptoms of an E. coli infection may include abdominal cramps, diarrhea, nausea, vomiting and sometimes fever. Certain strains can cause bloody diarrhea, and in severe cases, a potentially life-threatening complication known as hemolytic uremic syndrome, which can damage the kidneys.

Yeast and mold contamination can also indicate food spoilage or compromised product quality. Not all molds or yeasts are dangerous, but contaminated food should not be consumed.

The FDA's recall notice identifies E. coli, yeast, and mold as the reasons for the action but does not establish that every recalled package contains harmful microorganisms or identify a particular disease-causing strain of E. coli.

What consumers should do

Consumers who purchased the recalled butter should stop using it immediately, even if the product looks and smells normal.

They should check the lot code and best-by date and either discard the affected product or return it to the retailer where it was purchased. Some retailers, including Wegmans, are offering full refunds.

Consumers should also clean any utensils, containers, or refrigerator surfaces that may have come into contact with the recalled butter.

Anyone who develops severe abdominal pain, bloody diarrhea, or other significant symptoms after consuming the product should contact a healthcare professional.

Because the butter can be stored frozen, consumers should check their freezers as well as their refrigerators, even if they purchased the product several weeks ago.

The recall is a reminder that plant-based food products, like their dairy-based counterparts, can be subject to microbial contamination and food safety recalls.

New Ziploc packaging aims to simplify pouring and storage while keeping cereal fresher longer

By Mark Huffman of ConsumerAffairs

• Cheerios is introducing a resealable Ziploc bag inside its cereal boxes to help preserve freshness.

• A built-in pouring spout could mean fewer spills and less need for clips or separate storage containers.

• The packaging debuted for original and Honey Nut Cheerios on Walmart.com, with broader distribution planned.

Cheerios is addressing a familiar breakfast frustration: figuring out how to close the cereal bag after opening it so the contents dont become stale.

General Mills has partnered with Ziploc to introduce Cheerios with Ziploc PantrySeal, a packaging option that puts a resealable bag inside the traditional cardboard box.

The bag opens partway across the top, forming a pouring spout, and can then be sealed inside the box. General Mills says the design makes serving easier and helps maintain freshness. The cereal itself remains the same.

Why it matters

For consumers, the potential benefit extends beyond convenience. If the closure helps households finish a box before its contents become stale, it could reduce food waste and stretch the money spent on breakfast.

That could be especially useful for people who eat cereal occasionally or keep several varieties open at once. A more controlled opening could also mean fewer Os scattered across the counter.

General Mills says the change responds to years of consumer feedback. A December 2025 Suzy survey cited by the company found that 90% of cereal consumers already take additional steps to preserve freshness, including rolling or clipping bags and transferring cereal into containers.

Starting with Walmart

The packaging became available for original Cheerios and Honey Nut Cheerios exclusively through Walmart.com on Oct. 27. General Mills plans to expand distribution to retailers nationwide in the coming months.

The announcement did not specify how much longer cereal would stay fresh or provide a suggested retail price. Shoppers evaluating the new option should compare prices per ounce, as any potential savings from less waste will depend partly on what they pay for the package.

Higher fuel costs and reduced competition are helping drive up prices at the discount airline

By Mark Huffman of ConsumerAffairs

• Frontiers average fare revenue per passenger rose 71% in the third quarter compared with a year earlier.

• The increase reflects higher fuel costs, changes in pricing strategy, and reduced competition following Spirit Airlines shutdown.

• The figure represents a quarterly average; it does not mean every Frontier ticket has received a 71% price increase.

Travelers counting on Frontier Airlines for inexpensive flights are facing sharply higher prices. The airline reported that average fare revenue per passenger reached $67.82 during July through September, up from $39.74 in the same period last year an increase of 71%.

The figures, released during the companys quarterly earnings call, measure the airlines average fare revenue across its passengers. They describe an increase that has already occurred, rather than a newly announced, across-the-board fare hike. Individual ticket prices vary by route, travel date, and demand.

Fuel is a major source of pressure. Frontier paid an average of $3.96 per gallon during the quarter, 56% more than a year earlier. Its quarterly fuel expense totaled $425 million.

But higher energy costs do not explain the entire increase. According to The Points Guys coverage of Frontiers earnings call, CEO Jimmy Dempsey attributed the airlines revenue improvement roughly equally to fuel-related pricing, better revenue management, and the disappearance of competitor Spirit Airlines.

No more competition from Spirit

Spirit stopped flying in May, removing a major discount competitor. Before its shutdown, the two airlines overlapped on about 30% of routes, The Points Guy reported. Frontier has since added service on some former Spirit routes.

For consumers, that combination can mean fewer competing discount offers and less opportunity to escape higher prices simply by choosing a budget carrier.

The 71% figure also tells only part of the cost story. Frontiers total revenue per passenger, including ancillary and other revenue, increased 30% to $138.22. That is a broader company revenue measure, rather than the average advertised ticket price or an individual travelers final bill.

Higher prices have not stopped Frontier from attracting travelers. Reuters reported that management remained comfortable with the balance between fares and passenger demand, even as other airlines emphasized higher prices over filling every seat.

There is continuing pressure ahead: Frontier expects its average fuel cost to rise to $4.75 per gallon in the fourth quarter.

Travelers comparing flights should calculate the full checkout price, including any baggage, seating, or other options they need. Comparing that total across airlines along with departure times and airport transportation costs provides a clearer picture of whether a discount fare delivers savings.